白人患者中FcγRIIIa-V158F与FcγRIIa-H131R多态性之间存在连锁不平衡的证据，以及FcγRIIIa对治疗性抗体反应的限制性影响。 - Suppr

Suppr

超能文献

Evidence for linkage disequilibrium between Fcgamma RIIIa-V158F and Fcgamma RIIa-H131R polymorphisms in white patients, and for an Fcgamma RIIIa-restricted influence on the response to therapeutic antibodies.

作者信息

Lejeune Julien, Thibault Gilles, Ternant David, Cartron Guillaume, Watier Hervé, Ohresser Marc

出版信息

J Clin Oncol. 2008 Nov 20;26(33):5489-91; author reply 5491-2. doi: 10.1200/JCO.2008.19.4118. Epub 2008 Oct 27.

DOI:10.1200/JCO.2008.19.4118

PMID:18955438

Abstract

摘要

相似文献

Evidence for linkage disequilibrium between Fcgamma RIIIa-V158F and Fcgamma RIIa-H131R polymorphisms in white patients, and for an Fcgamma RIIIa-restricted influence on the response to therapeutic antibodies.白人患者中FcγRIIIa-V158F与FcγRIIa-H131R多态性之间存在连锁不平衡的证据，以及FcγRIIIa对治疗性抗体反应的限制性影响。

J Clin Oncol. 2008 Nov 20;26(33):5489-91; author reply 5491-2. doi: 10.1200/JCO.2008.19.4118. Epub 2008 Oct 27.

Genetic linkage of Fc gamma RIIa and Fc gamma RIIIa and implications for their use in predicting clinical responses to CD20-directed monoclonal antibody therapy.FcγRIIa和FcγRIIIa的基因连锁及其在预测CD20导向单克隆抗体治疗临床反应中的应用意义。

Clin Lymphoma Myeloma. 2007 Jan;7(4):286-90. doi: 10.3816/clm.2007.n.004.

Fcγ receptor predictive genomic testing and the treatment of indolent non-Hodgkin lymphoma.Fcγ受体预测性基因组检测与惰性非霍奇金淋巴瘤的治疗

Clin Lymphoma Myeloma Leuk. 2010 Oct;10(5):321-2. doi: 10.3816/CLML.2010.n.063.

Clearance of red cells by monoclonal IgG3 anti-D in vivo is affected by the VF polymorphism of Fcgamma RIIIa (CD16).体内单克隆IgG3抗-D对红细胞的清除受FcγRIIIa（CD16）的VF多态性影响。

Clin Exp Immunol. 2003 Apr;132(1):81-6. doi: 10.1046/j.1365-2249.2003.02119.x.

Fcγ receptor polymorphisms and clinical efficacy of rituximab in non-Hodgkin lymphoma and chronic lymphocytic leukemia.Fcγ 受体多态性与利妥昔单抗在非霍奇金淋巴瘤和慢性淋巴细胞白血病中的临床疗效。

Clin Lymphoma Myeloma Leuk. 2010 Oct;10(5):347-52. doi: 10.3816/CLML.2010.n.067.

FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population.焦磷酸测序法检测 FCGR2C 基因型与高加索人群 FCGR3A V158F 和 FCGR2A H131R 多态性的连锁不平衡

MAbs. 2012 Nov-Dec;4(6):784-7. doi: 10.4161/mabs.22287. Epub 2012 Oct 2.

Scientific Significance of Clinically Insignificant FcγRIIIa-V158F Polymorphism.FcγRIIIa-V158F 多态性的临床意义。

Clin Cancer Res. 2016 Feb 15;22(4):787-9. doi: 10.1158/1078-0432.CCR-15-2777. Epub 2015 Dec 18.

Fc gamma RIIIa and Fc gamma RIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia.FcγRIIIa和FcγRIIa基因多态性不能预测B细胞慢性淋巴细胞白血病患者对利妥昔单抗的反应。

Blood. 2004 Feb 15;103(4):1472-4. doi: 10.1182/blood-2003-07-2548. Epub 2003 Oct 16.

A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer.Fcγ 受体多态性在癌症中对单克隆抗体反应的作用的批判性评价。

J Hematol Oncol. 2013 Jan 4;6:1. doi: 10.1186/1756-8722-6-1.

Association of Fcgamma receptor IIA, but not IIB and IIIA, polymorphisms with systemic lupus erythematosus: A family-based association study in Caucasians.Fcγ受体IIA而非IIB和IIIA的多态性与系统性红斑狼疮的关联：一项基于家系的高加索人群关联研究

Arthritis Rheum. 2004 Feb;50(2):671-3. doi: 10.1002/art.20029.

引用本文的文献

Fc gamma receptors: Their evolution, genomic architecture, genetic variation, and impact on human disease.Fcγ受体：它们的进化、基因组结构、遗传变异及其对人类疾病的影响。

Immunol Rev. 2024 Nov;328(1):65-97. doi: 10.1111/imr.13401. Epub 2024 Sep 30.

Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients.英夫利昔单抗治疗患者 IgG1 抗体清除与 FcγRIIA 多态性和血小板计数的关系。

Int J Mol Sci. 2021 Jun 3;22(11):6051. doi: 10.3390/ijms22116051.

Genetic Variation in Low-To-Medium-Affinity Fcγ Receptors: Functional Consequences, Disease Associations, and Opportunities for Personalized Medicine.低-中亲和力 Fcγ 受体的遗传变异：功能后果、疾病关联以及个性化医学的机会。

Front Immunol. 2019 Oct 3;10:2237. doi: 10.3389/fimmu.2019.02237. eCollection 2019.

Expression, Role, and Regulation of Neutrophil Fcγ Receptors.中性粒细胞 Fcγ 受体的表达、作用和调控。

Front Immunol. 2019 Aug 27;10:1958. doi: 10.3389/fimmu.2019.01958. eCollection 2019.

Extensive Ethnic Variation and Linkage Disequilibrium at the Locus: Different Genetic Associations Revealed in Kawasaki Disease.广泛的种族差异和连锁不平衡在 Locus 上：川崎病中揭示了不同的遗传关联。

Front Immunol. 2019 Mar 21;10:185. doi: 10.3389/fimmu.2019.00185. eCollection 2019.

Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation.靶向肿瘤细胞和免疫检查点受体的治疗性抗体联合使用的原理：通过IgG1同种型免疫效应刺激来利用先天免疫和适应性免疫。

Cancer Treat Rev. 2018 Feb;63:48-60. doi: 10.1016/j.ctrv.2017.11.008. Epub 2017 Dec 2.

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer.免疫球蛋白G片段C受体多态性与术前化疗联合曲妥珠单抗和拉帕替尼治疗HER2阳性乳腺癌的疗效

Pharmacogenomics J. 2016 Oct;16(5):472-7. doi: 10.1038/tpj.2016.51. Epub 2016 Jul 5.

A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options.一种糖基工程化抗HER2单克隆抗体（TrasGEX）在所有可用治疗方案均失败后，使一名HER2过表达转移性结直肠癌患者实现了长期缓解。

J Clin Pathol. 2015 Dec;68(12):1044-6. doi: 10.1136/jclinpath-2015-202996. Epub 2015 Sep 18.

Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art.抗中性粒细胞胞质抗体相关性血管炎的遗传易感性：最新进展。

Front Immunol. 2014 Nov 17;5:577. doi: 10.3389/fimmu.2014.00577. eCollection 2014.

Contribution of Human FcγRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies.人类Fcγ受体对疾病的贡献：来自人类多态性和转基因动物研究的证据

Front Immunol. 2014 May 30;5:254. doi: 10.3389/fimmu.2014.00254. eCollection 2014.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验